Survival and Prognostic Factors for Breast Cancer Patients with Regional Oligo-Recurrence.

ABSTRACT:

Purpose

This study aimed to evaluate survival outcomes and identify prognostic factors for regional oligo-recurrence in breast cancer patients who received salvage local treatment.

Methods

In the breast cancer registry of our institution, 18,790 patients received curative surgery for stage I-III breast cancer between January 1995 and June 2016. Of those patients, only 87 (0.5%)underwent salvage local treatment for isolated nodal recurrence on the axillary lymph nodes (ALNs) (n = 58), supraclavicular lymph nodes (SCNs) (n = 17), or internal mammary lymph nodes (IMNs) (n = 12).

Results

The median follow-up duration after regional oligo-recurrence was 49 months (range: 6-194 months). For patients with recurrence of ALN, SCN, or IMN, the 5-year progression-free survival (

SUBMITTER: Baek JY 

PROVIDER: S-EPMC7779728 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature